Atlas Arteria (ASX:ALX) - Aandelenkoers, Nieuws & Analyse

ALX Overzicht aandelen

Atlas Arteria Limited bezit, ontwikkelt en exploiteert tolwegen. Meer informatie

ALX fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	4/6
Prestaties in het verleden	2/6
Financiële gezondheid	3/6
Dividenden	4/6

Beloningen

Verhandeld tegen 49.4% onder onze schatting van de reële waarde

De winst zal naar verwachting met 21.84% per jaar groeien

Risicoanalyse

Het dividend van 8.4% wordt niet goed gedekt door de winst of de vrije kasstromen

Atlas Arteria Limited Concurrenten

Transurban Group

ASX:TCL

AU$39.0b

Qube Holdings

ASX:QUB

AU$6.9b

Aurizon Holdings

ASX:AZJ

AU$6.1b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.7b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Atlas Arteria
Historische aandelenkoersen
Huidige aandelenkoers	AU$4.76
52 Week Hoogtepunt	AU$5.88
52 Week Laag	AU$4.63
Bèta	0.76
11 maand verandering	-4.80%
3 maanden verandering	-6.67%
1 Jaar Verandering	-17.36%
33 jaar verandering	-30.61%
5 jaar verandering	-38.18%
Verandering sinds IPO	673.98%

Recent nieuws en updates

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Rendement voor aandeelhouders

	ALX	AU Infrastructure	AU Markt
7D	-0.6%	0.6%	1.5%
1Y	-17.4%	-0.7%	17.2%

Rendement versus industrie: ALX presteerde slechter dan de Australian Infrastructure -sector, die het afgelopen jaar een rendement van -0.7 % opleverde.

Rendement versus markt: ALX presteerde slechter dan Australian Market, dat het afgelopen jaar een rendement van 17.2 % opleverde.

Prijsvolatiliteit

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	3.1%
Infrastructure Industry Average Movement	2.6%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Stabiele aandelenkoers: ALX heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van ALX is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited bezit, ontwikkelt en exploiteert tolwegen. Het heeft een belang van 31,14% in de APRR en A79 en 31,17% in de ADELAC gelegen in Frankrijk; 100% belang in de Warnow Tunnel gelegen in Rostock, Duitsland; 66,67% belang in de Chicago Skyway gelegen in Chicago en 100% belang in de Dulles Greenway gelegen in Virginia, Verenigde Staten. Het bedrijf was voorheen bekend als Macquarie Atlas Roads Limited en veranderde zijn naam in Atlas Arteria Limited in mei 2018.

Atlas Arteria Limited Samenvatting

Hoe verhouden de winst en inkomsten van Atlas Arteria zich tot de beurswaarde?
ALX fundamentele statistieken
Marktkapitalisatie	AU$6.91b
Inkomsten(TTM)	AU$300.20m
Inkomsten(TTM)	AU$140.10m

23.0x

Koers/Winstverhouding

49.3x

P/S-verhouding

Is ALX overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ALX resultatenrekening (TTM)
Inkomsten	AU$140.10m
Kosten van inkomsten	AU$47.80m
Brutowinst	AU$92.30m
Overige uitgaven	-AU$207.90m
Inkomsten	AU$300.20m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Feb 26, 2025

Winst per aandeel (EPS)	0.21
Brutomarge	65.88%
Nettowinstmarge	214.28%
Schuld/Eigen Vermogen Verhouding	27.2%

Hoe presteerde ALX op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

8.4%

Huidig dividendrendement

194%

Uitbetalingsratio

ALX Overzicht aandelen

Beloningen

Risicoanalyse

Atlas Arteria Limited Concurrenten

ASX:TCL

AU$39.0b

ASX:QUB

AU$6.9b

ASX:AZJ

AU$6.1b

ASX:DBI

AU$1.7b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021